PFM Health Sciences’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-345,926
| Closed | -$384K | – | 87 |
|
|
2022
Q4 | $384K | Sell |
345,926
-3,748,562
| -92% | -$4.16M | 0.01% | 74 |
|
|
2022
Q3 | $9.58M | Buy |
4,094,488
+144,820
| +4% | +$339K | 0.35% | 61 |
|
|
2022
Q2 | $12M | Sell |
3,949,668
-23,200
| -0.6% | -$70.3K | 0.46% | 53 |
|
|
2022
Q1 | $27M | Hold |
3,972,868
| – | – | 1.01% | 40 |
|
|
2021
Q4 | $33.2M | Buy |
3,972,868
+124,046
| +3% | +$1.04M | 1.13% | 40 |
|
|
2021
Q3 | $28.6M | Buy |
3,848,822
+585,989
| +18% | +$4.35M | 0.84% | 39 |
|
|
2021
Q2 | $22.2M | Hold |
3,262,833
| – | – | 0.7% | 45 |
|
|
2021
Q1 | $33.5M | Buy |
+3,262,833
| New | +$33.5M | 1.02% | 34 |
|
|
2018
Q2 | – | Sell |
-1,923,651
| Closed | -$43M | – | 121 |
|
|
2018
Q1 | $43M | Sell |
1,923,651
-163,573
| -8% | -$3.66M | 0.87% | 40 |
|
|
2017
Q4 | $26.6M | Buy |
2,087,224
+359,227
| +21% | +$4.58M | 0.63% | 53 |
|
|
2017
Q3 | $26.9M | Buy |
1,727,997
+1,029,838
| +148% | +$16M | 0.53% | 53 |
|
|
2017
Q2 | $9.8M | Buy |
698,159
+199,445
| +40% | +$2.8M | 0.26% | 75 |
|
|
2017
Q1 | $11M | Buy |
+498,714
| New | +$11M | 0.27% | 77 |
|